The global market place for tailored medication is poised to achieve $3.18 trillion over the coming half-decade. While cellular and genetic therapy paradigms offer myriad benefits for biotech enterprises and their clientele, realizing treatments for patients presents numerous hurdles. Luckily, the emergence and progression of artificial intelligence arrive opportunistically to aid life sciences...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian